<!DOCTYPE html><html><head><title>Help for package BioPETsurv</title>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
<link href="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/themes/prism.min.css" rel="stylesheet" />
<link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.css">
<script type="text/javascript">
const macros = { "\\R": "\\textsf{R}", "\\code": "\\texttt"};
function processMathHTML() {
    var l = document.getElementsByClassName('reqn');
    for (let e of l) { katex.render(e.textContent, e, { throwOnError: false, macros }); }
    return;
}</script>
<script defer src="https://cdn.jsdelivr.net/npm/katex@0.15.3/dist/katex.min.js"
    onload="processMathHTML();"></script>
<link rel="stylesheet" type="text/css" href="R-nav.css" />
</head><body><div class="container"><nav class="package" aria-label="Topic Navigation">
<div class="dropdown-menu">
<h1>Package {BioPETsurv}</h1>
<h2>Contents</h2>
<ul class="menu">
<li><a href='#sim_data'><p>Simulating Biomarker and Survival Observations</p></a></li>
<li><a href='#surv_enrichment'><p>Prognostic Enrichment for Clinical Trials with Survival Outcomes</p></a></li>
<li><a href='#surv_plot_enrichment'><p>Plotting Clinical Trial Metrics for Prognostic Enrichment</p></a></li>
<li><a href='#SurvMarkers'><p>Example dataset for package 'BioPETsurv'</p></a></li>
</ul>
</div>
<hr>
</nav>
<main>
<table>
<tr>
<td>Type:</td>
<td>Package</td>
</tr>
<tr>
<td>Title:</td>
<td>Biomarker Prognostic Enrichment Tool for Time-to-Event Trial</td>
</tr>
<tr>
<td>Version:</td>
<td>0.1.0</td>
</tr>
<tr>
<td>Description:</td>
<td>Prognostic Enrichment is a strategy of enriching a clinical trial for testing an intervention intended to prevent or delay an unwanted clinical event.  A prognostically enriched trial enrolls only patients who are more likely to experience the unwanted clinical event than the broader patient population (R. Temple (2010) &lt;<a href="https://doi.org/10.1038%2Fclpt.2010.233">doi:10.1038/clpt.2010.233</a>&gt;). By testing the intervention in an enriched study population, the trial may be adequately powered with a smaller sample size, which can have both practical and ethical advantages.
    This package provides tools to evaluate biomarkers for prognostic enrichment of clinical trials with survival/time-to-event outcomes.</td>
</tr>
<tr>
<td>Depends:</td>
<td>R (&ge; 3.1.0)</td>
</tr>
<tr>
<td>License:</td>
<td><a href="https://www.r-project.org/Licenses/GPL-2">GPL-2</a> | <a href="https://www.r-project.org/Licenses/GPL-3">GPL-3</a> [expanded from: GPL (&ge; 2)]</td>
</tr>
<tr>
<td>Encoding:</td>
<td>UTF-8</td>
</tr>
<tr>
<td>LazyData:</td>
<td>true</td>
</tr>
<tr>
<td>RoxygenNote:</td>
<td>6.1.1</td>
</tr>
<tr>
<td>Imports:</td>
<td>survival, ggplot2, gridExtra</td>
</tr>
<tr>
<td>NeedsCompilation:</td>
<td>no</td>
</tr>
<tr>
<td>Packaged:</td>
<td>2020-01-08 18:03:28 UTC; Si Cheng</td>
</tr>
<tr>
<td>Author:</td>
<td>Si Cheng [cre, aut],
  Kathleen F. Kerr [ctb]</td>
</tr>
<tr>
<td>Maintainer:</td>
<td>Si Cheng &lt;chengsi@uw.edu&gt;</td>
</tr>
<tr>
<td>Repository:</td>
<td>CRAN</td>
</tr>
<tr>
<td>Date/Publication:</td>
<td>2020-01-12 10:20:02 UTC</td>
</tr>
</table>
<hr>
<h2 id='sim_data'>Simulating Biomarker and Survival Observations</h2><span id='topic+sim_data'></span>

<h3>Description</h3>

<p>This function simulates biomarkers and generates survival observations depending on biomarker values. The simulated data can be used to explore prognostic enrichment using <code>surv_enrichment</code>.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>sim_data(n = 500, biomarker = "normal", effect.size = 1.25,
         baseline.hazard = "constant", end.time = 10,
         end.survival = 0.5, shape = NULL, seed = 2333)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="sim_data_+3A_n">n</code></td>
<td>

<p>The number of observations to simulate.
</p>
</td></tr>
<tr><td><code id="sim_data_+3A_biomarker">biomarker</code></td>
<td>

<p>Character specifying the shape of the biomarker distribution. Choices are <code>normal</code> for a symmetric distribution and <code>lognormal</code> for a right-skewed distribution.
</p>
</td></tr>
<tr><td><code id="sim_data_+3A_effect.size">effect.size</code></td>
<td>

<p>The hazard ratio corresponding to one standard deviation increment in the biomarker.
</p>
</td></tr>
<tr><td><code id="sim_data_+3A_baseline.hazard">baseline.hazard</code></td>
<td>

<p>Character (&quot;constant&quot;/&quot;increasing&quot;/&quot;decreasing&quot;) specifying whether the overall hazard in the population is constant, increasing or decreasing over time.
</p>
</td></tr>
<tr><td><code id="sim_data_+3A_end.time">end.time</code></td>
<td>

<p>The length of observation in the simulated dataset. In the data simulation, any events after this time will be censored at this time.
</p>
</td></tr>
<tr><td><code id="sim_data_+3A_end.survival">end.survival</code></td>
<td>

<p>The survival rate in the population at the end of observation.
</p>
</td></tr>
<tr><td><code id="sim_data_+3A_shape">shape</code></td>
<td>

<p>(Optional) the Weibull shape parameter for the baseline hazard. Values smaller and larger than 1 correspond to decreasing and increasing respectively.
</p>
</td></tr>
<tr><td><code id="sim_data_+3A_seed">seed</code></td>
<td>

<p>(Optional) specify the random seed used for simulation.
</p>
</td></tr>
</table>


<h3>Details</h3>

<p>The biomarker will be simulated from a standardized normal or lognormal distribution. It is important that <code>effect.size</code> should correspond to a 1 SD increment in the biomarker. Conditioning on the biomarker values and assuming proportional hazards, survival times are simulated from a Weibull distribution with user-specified shape parameter, and the scale parameter is determined by the specified event rate and effect size.
</p>


<h3>Value</h3>

<p>Returns a list of the following items:
</p>
<table>
<tr><td><code>data</code></td>
<td>

<p>A data frame with 4 columns: the value of biomarker, observed event time, event indicator and the true event time.
</p>
</td></tr>
<tr><td><code>km.plot</code></td>
<td>

<p>The Kaplan-Meier survival curves of the simulated dataset at enrichment levels 0, 25%, 50% and 75%.
</p>
</td></tr>
</table>


<h3>Examples</h3>

<pre><code class='language-R'>  ## Simulate a dataset with 500 observations,
  ## where the biomarker is Normally distributed (with SD=1).
  ## The hazard ratio corresponding to every one unit of increament in the biomarker is 1.25.
  ## The observation period is 10 months,
  ## and the survival probability of the population at the end of observation is 0.5.
  ## Hazards are constant over time.
  sim_obj &lt;- sim_data(n = 500, biomarker = "normal", effect.size = 1.25,
                     baseline.hazard = "constant", end.time = 10, end.survival = 0.5)
  dat &lt;- sim_obj$data
</code></pre>

<hr>
<h2 id='surv_enrichment'>Prognostic Enrichment for Clinical Trials with Survival Outcomes</h2><span id='topic+surv_enrichment'></span>

<h3>Description</h3>

<p>This function evaluates biomarkers for prognostic enrichment of clinical trials with survival outcomes, using data with biomarker values and survival observations.
A more detailed tutorial is available <a href="https://github.com/chengs94/BioPETsurv/blob/master/README.md">here</a>.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>surv_enrichment(formula, data, hr = 0.8, end.of.trial=NULL, a=NULL, f=NULL,
     method = "KM", lambda = 0.05,
     cost.screening = NULL, cost.keeping = NULL, cost.unit.keeping = NULL,
     power = 0.9, alpha = 0.05, one.sided = FALSE,
     selected.biomarker.quantiles = seq(from = 0, to = 0.95, by = 0.05),
     do.bootstrap = FALSE, n.bootstrap = 1000, seed = 2333,
     print.summary.tables = FALSE)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="surv_enrichment_+3A_formula">formula</code></td>
<td>

<p>Object of class <code>formula</code>, in the form <code>outcome</code> ~ <code>predictors</code>, where the outcome is a survival object as returned by function <code>Surv()</code>. The predictor(s) include the biomarker(s) of interest and/or other covariates. If multiple predictors are inputed, this function will consider a composite biomarker based on a Cox model with all predictors.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_data">data</code></td>
<td>

<p>Data frame containing the survival outcome (as returned by <code>Surv()</code>) and predictors specified in the <code>formula</code> argument. Observations with missing value(s) will be dropped.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_hr">hr</code></td>
<td>

<p>The hazard ratio (comparing the treatment versus control group) that the trial seeks to detect. Should be a number between 0 and 1.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_end.of.trial">end.of.trial</code></td>
<td>

<p>A scalar or a vector that gives the duration(s) of fixed-length trial(s) that are being considered. The unit of time should be the same as the survival times in the data. Either <code>end.of.trial</code> or a combination of <code>a</code> and <code>f</code> must be specified.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_a">a</code></td>
<td>

<p>A scalar specifying the accrual period of the trial. It is assumed that patients are recruited at a uniform rate during this period.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_f">f</code></td>
<td>

<p>A scalar specifying the follow-up period of the trial, that is, all patients are followed during this period right after the accrual period.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_method">method</code></td>
<td>

<p>Character specifying which method would be used to estimate event probabilities. Choices are <code>KM</code> for the Kaplan-Meier estimator and <code>NNE</code> for the nearest neighbor estimator described in Heagerty et al (2000). Algorithm of NNE was adapted from the code in the <code>survivalROC</code> R package. If <code>method = "NNE"</code> is specified, only fixed-length trials (instead of accrual and follow-up) and <code>cost.keeping</code> (instead of <code>cost.unit.keeping</code>) can be specified, and no standard errors will be estimated. Default is <code>KM</code>.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_lambda">lambda</code></td>
<td>

<p>The smoothing parameter used by method <code>NNE</code> (see documentation of package <code>survivalROC</code>). Default is 0.05.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_cost.screening">cost.screening</code></td>
<td>

<p>(Optional) the cost of measuring the biomarker for each patient to determine eligibility for the trial.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_cost.keeping">cost.keeping</code></td>
<td>

<p>(Optional) the cost of enrolling and retaining a patient in a trial. If specified for a trial with accrual and follow-up periods, it is treated as the &quot;average&quot; cost for one patient under such design, and is used for all patients in the trial.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_cost.unit.keeping">cost.unit.keeping</code></td>
<td>

<p>(Optional) the cost of enrolling and retaining a patient per unit time in the trial. Can be specified as an alternative to <code>cost.keeping</code>, assuming that patients who experienced a clinical event no longer cost in the trial.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_power">power</code></td>
<td>

<p>The power (probability of rejecting the null hypothesis given that it is false) for sample size calculation.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_alpha">alpha</code></td>
<td>

<p>The type I error rate (probability of falsely rejecting the null given that it is true) for sample size calculation.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_one.sided">one.sided</code></td>
<td>

<p>Logical indicating whether the alternative hypothesis is one-sided (instead of two-sided). Default is <code>FALSE</code>.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_selected.biomarker.quantiles">selected.biomarker.quantiles</code></td>
<td>

<p>Numeric vector specifying the quantiles of the biomarker measured in controls that will be used to screen trial participants. Default is 0, 0.05, ..., 0.95. All entries must be between at least 0 and less than 1.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_do.bootstrap">do.bootstrap</code></td>
<td>

<p>Logical specifying whether bootstrap standard errors should be calculated for a trial with accrual and follow-up periods. Default is <code>FALSE</code>. (Standard errors will always be calculated for fixed-length trials.)
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_n.bootstrap">n.bootstrap</code></td>
<td>

<p>Number of bootstrap samples for standard error estimation.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_seed">seed</code></td>
<td>

<p>Specify the random seed used to generate bootstrap samples.
</p>
</td></tr>
<tr><td><code id="surv_enrichment_+3A_print.summary.tables">print.summary.tables</code></td>
<td>

<p>Logical specifying whether a table of clinical trial metrics should be printed.
</p>
</td></tr>
</table>


<h3>Value</h3>

<p>Returns a list of the following items:
</p>
<table>
<tr><td><code>summary.table</code></td>
<td>

<p>A matrix containing all clinical trial metrics that were calculated (listed below) at each enrichment level.
</p>
</td></tr>
<tr><td><code>event.prob</code></td>
<td>

<p>Vector(s) of estimated event probabilities at each enrichment level. If more than one vector was presented, each column corresponds to a specified length of trial.
</p>
</td></tr>
<tr><td><code>event.prob.se</code></td>
<td>

<p>Estimated standard errors of event probabilities at each enrichment level for each trial length.
</p>
</td></tr>
<tr><td><code>n.patients</code></td>
<td>

<p>Vector(s) of clinical trial sample size required.
</p>
</td></tr>
<tr><td><code>n.patients.se</code></td>
<td>

<p>Estimated standard errors of the sample sizes.
</p>
</td></tr>
<tr><td><code>n.screened</code></td>
<td>

<p>The number of patients that need to be screened to enroll the trial.
</p>
</td></tr>
<tr><td><code>n.screened.se</code></td>
<td>

<p>Estimated standard errors of <code>n.screened</code>.
</p>
</td></tr>
<tr><td><code>cost</code></td>
<td>

<p>The estimated total cost of the trial, combining screening costs and the total cost of patients in the trial.
</p>
</td></tr>
<tr><td><code>cost.se</code></td>
<td>

<p>Estimated standard errors of <code>cost</code>.
</p>
</td></tr>
<tr><td><code>cost.reduction</code></td>
<td>

<p>The reduction in total cost comparing an enriched trial to an unenriched trial. A positive number indicates that an enriched trial would cost less than an unenriched one.
</p>
</td></tr>
<tr><td><code>cost.reduction.se</code></td>
<td>

<p>Estimated standard errors of <code>cost.reduction</code> from bootstrap.
</p>
</td></tr>
<tr><td><code>response</code></td>
<td>

<p>The response (a Survival object) specified in argument <code>formula</code>.
</p>
</td></tr>
<tr><td><code>biomarker</code></td>
<td>

<p>The biomarker, or the composite biomarker calculated via Cox regression.
</p>
</td></tr>
</table>
<p>All other quantities are the same as the input by user.
</p>


<h3>References</h3>

<p>Heagerty, Patrick J., Thomas Lumley, and Margaret S. Pepe (2000) &lt;doi:10.1111/j.0006-341x.2000.00337.x&gt; &quot;Time-dependent ROC curves for censored survival data and a diagnostic marker&quot;
</p>
<p>Heagerty, Patrick J., Paramita Saha-Chaudhuri, and Maintainer Paramita Saha-Chaudhuri (2013) &lt;https://cran.r-project.org/web/packages/survivalROC/survivalROC.pdf&gt; &quot;Package 'survivalROC'.&quot;
</p>


<h3>Examples</h3>

<pre><code class='language-R'>require(survival)
data(SurvMarkers)

SurvMarkers$surv &lt;- Surv(SurvMarkers$time, SurvMarkers$event)

## Using a composite biomarker (combining x1 and x2) to plan a trial
## with an accrual period of 12 months and a follow-up period of 36 months.
## The cost for keeping a patient in the trial is $300/month.
## We wish to detect a hazard ratio of 0.8 with a two-sided test,
## with type I error 0.05 and power 0.9.
## The Kaplan-Meier method is used to calculate event probabilities.
rslt &lt;- surv_enrichment(formula = surv~x1+x2, data = SurvMarkers, hr = 0.8, a=12, f=36,
                         cost.screening = 300, cost.keeping = NULL, cost.unit.keeping = 300,
                         method = "KM", power = 0.9, alpha = 0.05, one.sided = FALSE,
                         selected.biomarker.quantiles = seq(from = 0, to = 0.9, by = 0.1),
                         do.bootstrap = FALSE, print.summary.tables = FALSE)
</code></pre>

<hr>
<h2 id='surv_plot_enrichment'>Plotting Clinical Trial Metrics for Prognostic Enrichment</h2><span id='topic+surv_plot_enrichment'></span>

<h3>Description</h3>

<p>This function plots summaries of prognostic enrichment of clinical trials with survival outcomes, based on clinical trial metrics estimated by <code>surv_enrichment</code>.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>surv_plot_enrichment(x, km.quantiles = c(0,0.25,0.5,0.75),
                     km.range = NULL, alt.color = NULL)
</code></pre>


<h3>Arguments</h3>

<table>
<tr><td><code id="surv_plot_enrichment_+3A_x">x</code></td>
<td>

<p>Object returned by <code>surv_enrichment</code>.
</p>
</td></tr>
<tr><td><code id="surv_plot_enrichment_+3A_km.quantiles">km.quantiles</code></td>
<td>

<p>Enrichment levels on which Kaplan-Meier survival estimates (Plot 1) are plotted. Defaults to four quartiles.
</p>
</td></tr>
<tr><td><code id="surv_plot_enrichment_+3A_km.range">km.range</code></td>
<td>

<p>(Optional) a scalar specifying the range of time for which Kaplan-Meier survival estimates (Plot 1) are plotted. Defaults to the last time point of observation.
</p>
</td></tr>
<tr><td><code id="surv_plot_enrichment_+3A_alt.color">alt.color</code></td>
<td>

<p>(Optional) allows the user to specify the color of curves for clinical trial metrics (Plots 2-6). The length should match the number of trial lengths considered. Defaults to <code>ggplot2</code> color palette.
</p>
</td></tr>
</table>


<h3>Value</h3>

<p>A grid containing either the first 4 or 6 plots described below.
</p>
<table>
<tr><td><code>km.plot</code></td>
<td>

<p>The Kaplan-Meier survival curves for specified enrichment levels. The vertical reference line(s) correspond to <code>end.of.trial</code> or <code>a,f</code>. This will be presented even if <code>method = "NNE"</code> was specified.
</p>
</td></tr>
<tr><td><code>prob.plot</code></td>
<td>

<p>The estimated event probability (and 95% confidence intervals) at each enrichment level.
</p>
</td></tr>
<tr><td><code>ss.plot</code></td>
<td>

<p>The estimated sample size (and confidence intervals) at each enrichment level.
</p>
</td></tr>
<tr><td><code>screen.plot</code></td>
<td>

<p>The estimated number of patients that need to be screened (and confidence intervals) to enroll the trial.
</p>
</td></tr>
<tr><td><code>cost.plot</code></td>
<td>

<p>The estimated total cost of the trial (and confidence intervals).
</p>
</td></tr>
<tr><td><code>reduction.cost.plot</code></td>
<td>

<p>The percentage of reduction in total cost comparing an enriched versus unenriched trial.
</p>
</td></tr>
<tr><td><code>summary</code></td>
<td>

<p>A grid of the first 4 or all 6 plots combined together.
</p>
</td></tr>
</table>


<h3>Examples</h3>

<pre><code class='language-R'>## Following the example of 'surv_enrichment':
data(SurvMarkers)
library(survival)

SurvMarkers$surv &lt;- Surv(SurvMarkers$time, SurvMarkers$event)
rslt &lt;- surv_enrichment(formula = surv~x1+x2, data = SurvMarkers, hr = 0.8, a=12, f=36,
                         cost.screening = 300, cost.keeping = NULL, cost.unit.keeping = 300,
                         method = "KM", power = 0.9, alpha = 0.05, one.sided = FALSE,
                         selected.biomarker.quantiles = seq(from = 0, to = 0.9, by = 0.1),
                         do.bootstrap = FALSE, print.summary.tables = FALSE)

plots &lt;- surv_plot_enrichment(rslt, km.quantiles = c(0,0.25,0.5,0.75))
</code></pre>

<hr>
<h2 id='SurvMarkers'>Example dataset for package 'BioPETsurv'</h2><span id='topic+SurvMarkers'></span>

<h3>Description</h3>

<p>A dataset containing values of two biomarkers and survival outcomes of 1533 individuals.
</p>


<h3>Usage</h3>

<pre><code class='language-R'>data(SurvMarkers)
</code></pre>


<h3>Format</h3>

<p>A data frame with 1533 rows and 4 variables:
</p>

<dl>
<dt>time</dt><dd><p>observed times of event or censoring</p>
</dd>
<dt>event</dt><dd><p>indicator of event; 0 means censored and 1 means event</p>
</dd>
<dt>x1</dt><dd><p>A modestly prognostic biomarker (concordance index=0.64)</p>
</dd>
<dt>x2</dt><dd><p>A strongly prognostic biomarker (concordance index=0.82)</p>
</dd>
</dl>

</main>

</div>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/prism.min.js"></script>
<script src="https://cdnjs.cloudflare.com/ajax/libs/prism/1.29.0/components/prism-r.min.js"></script>
</body></html>
